Abstract
Chromosomal translocations involving fusions of the human ETV6 (TEL1) gene occur frequently in hematologic malignancies. However, a detailed understanding of the normal function of ETV6 remains incomplete. This study has employed zebrafish as a relevant model to investigate the role of ETV6 during embryonic hematopoiesis. Zebrafish possessed a single conserved etv6 ortholog that was expressed from 12 hpf in the lateral plate mesoderm, and later in hematopoietic, vascular and other tissues. Morpholino-mediated gene knockdown of etv6 revealed the complex contribution of this gene toward embryonic hematopoiesis. During primitive hematopoiesis, etv6 knockdown resulted in reduced levels of progenitor cells, erythrocyte and macrophage populations, but increased numbers of incompletely differentiated heterophils. Definitive hematopoiesis was also perturbed, with etv6 knockdown leading to decreased erythrocytes and myeloid cells, but enhanced lymphopoiesis. This study suggests that ETV6 plays a broader and more complex role in early hematopoiesis than previously thought, impacting on the development of multiple lineages.Introduction
The ETV6 (ETS variant 6), also known as TEL1 (translocating E26 transforming-specific leukemia 1), gene encodes a nuclear phosphoprotein belonging to the ETS family of transcription factors, which collectively play important roles in a diverse range of cellular processes, including proliferation, differentiation, apoptosis and transformation.1 ETV6 is widely expressed during embryonic development, with higher levels of expression observed in the developing kidney, liver and lung, as well as the cranial nerve ganglia, dorsal root ganglia and the ventral region of the caudal neural tube,2 and shows broad expression in the adult, including in various hematopoietic cells.2 Like other ETS family members, ETV6 possesses two conserved domains: a PNT (pointed) or HLH (helix-loop-helix) domain at its N-terminus and an ETS domain at its C-terminus, and has been identified as a strong transcriptional repressor.43 The PNT domain is responsible for both homodimerization and heterodimerization with a range of proteins, including the closely-related ETV7 (TEL2) protein, the ETS family member FLI1 and the ubiquitin-conjugating enzyme UBC90.64 This domain is required for the repression of target genes,5 and also mediates the nuclear export of ETV6, thereby regulating its activity.7 The positively charged ETS domain is responsible for binding to purine rich segments of DNA, recognizing a core GGAA/T sequence.8 A less conserved central domain contributes to the strong repressional activity of ETV6 through binding of various co-repressors, including mSin3A, SMRT, and N-CoR, which subsequently recruit histone deacetylases to mediate transcriptional repression.1094
The human ETV6 gene is located in a region on the short arm of chromosome 12 that is notable for its frequent involvement in chromosomal translocations associated with hematologic malignancies. Around 50 different translocations involving ETV6 have been reported, involving around 30 partner genes.11 Alternate functional domains of ETV6 are represented in these fusions. For example, fusions with JAK212 and RUNX113 involve the PNT domain of ETV6, while MN1 fusions involve the ETS domain.14 Moreover, diverse molecular mechanisms can contribute to the pathogenesis of leukemia resulting from ETV6 fusion, including mislocalization of partner kinases or functional disruption of partner transcription factors.93 Interestingly, in many cases, leukemic cells harboring ETV6 translocations possess no functional ETV6 protein due to deletion of the wild-type ETV6 allele,161513 specific point mutations leading to truncated unstable forms of ETV6,17 or dominant negative effects of the fusion protein over normal ETV6 function.11 This observation suggests a negative regulatory role for ETV6 within the hematopoietic transcriptional hierarchy, underpinning a likely tumor suppressor function for this protein.
Targeted knockout of Etv6 in mice resulted in embryonic lethality at the E10.5–11.5 stage of development due to apoptosis of mesenchymal and neural cells and defective yolk sac angiogenesis.2 Further analysis using chimeric mice revealed that Etv6 was essential for the establishment of definitive hematopoiesis in the bone marrow.18 Consistent with these findings, knockdown of etv6 in Xenopus revealed a requirement for this gene in the formation of the first definitive hematopoietic stem cells in the dorsal aorta.19 Conditional knockout of Etv6 in adult mice identified an essential role in survival of adult hematopoietic stem cells (HSCs) within the hematopoietic niches.20 However, ablation of Etv6 after lineage commitment did not affect adult hematopoiesis, except for specific maturation defects in the megakaryocyte lineage.20 In contrast, transgenic mice expressing human ETV6 under control of the Gata1 promoter showed accelerated proliferation of early erythroid progenitors, and increased erythroid differentiation.21
Zebrafish is an established model for the study of hematopoiesis, showing broad conservation with mammalian species, including distinct primitive and definitive waves of development.22 Zebrafish primitive hematopoietic progenitors are initially derived from hemangioblasts within the lateral plate mesoderm,22 and express early hematopoietic genes, such as scl and ikaros.2423 From these progenitors, foci for myeloid (spi1) and erythromyeloid (gata1, spi1) generation are established.2625 Rostrally, macrophage cells expressing lysozyme (lyz) are produced,27 and caudally there is production of erythroid cells expressing β-embryonic globin (β-e-g)28 and heterophilic granulocytes expressing myeloperoxidase (mpo) and matrix metalloproteinase 9 (mmp9).3029 Finally, from the dorsal aorta emerge definitive hematopoietic stem cells (HSCs) expressing c-myb.31 Following a transient phase within the caudal hematopoietic tissue,31 these HSCs seed the developing kidney, which becomes the principal site of hematopoiesis, and the thymus. Here early ikaros+ lymphoid precursors yield mature rag1+ T cells.3224
In previous studies, we and others have shown that zebrafish is susceptible to the effects of the ETV6-JAK23433 and ETV6-AML135 oncogenes, which has validated this organism as a useful model for the study of leukemogenesis as well as ETV6. Here we have taken further advantage of this model to investigate the function of ETV6 during embryogenesis. This has identified several distinct roles for ETV6 in embryonic hematopoiesis with implications for understanding its role in leukemogenesis.
Methods
Zebrafish maintenance and manipulation
All work involving zebrafish was approved by the Deakin University Animal Ethics Committee. Wild-type zebrafish stocks were maintained using standard husbandry practices, as described.34 Two anti-sense morpholinos (Gene Tools) targeting zebrafish etv6 were used: a splice-blocking morpholino targeting the exon II/intron II splice junction (SSmo: 5′-ACACAGAAAAT-GCAGATTTACCTTA) and one targeting the 5′ untranslated region (UTRmo: 5′-TCTTGTGTTTCCACTTTCCTCTCCT), as well as one targeting the lycat gene (5′-CTGAACACACACACT-GACCGAAGC),36 and a control scrambled morpholino (Co: 5′-CCTCTTACCTCAGTTACAATTTATA). In addition, morpholino-resistant mRNA encoding Flag-tagged etv6 was generated by in vitro transcription, as described.33 Embryos were microinjected at the 1 cell stage with SSmo (8 fmol) and UTRmo (16 fmol) alone or in combination with the morpholino-resistant etv6 mRNA (0.6 ng) using finely drawn capillaries, and raised at 28°C in egg water (2.5% (w/v) Na2HPO4; pH 6.0–6.3) containing 0.003% (w/v) 1-phenyl-2-thiourea to inhibit pigment formation.
RT-PCR and Q-RT-PCR
Total RNA was isolated from pools of 30 whole wild-type or morphant zebrafish embryos at different developmental time points using TRIzol (Invitrogen), except for c-myb analysis when embryos were manually dissected into rostral and caudal segments. The RNA was reverse transcribed to cDNA using an iScript cDNA synthesis kit (Bio-Rad). To confirm the effectiveness of the splice site blocking morpholino, PCR was performed using GoTaq Green Master Mix (Promega) and primers specific for exon 1 (5′-CCGGAAGGTGTTAACCATCG) and exon 3 (5′-GAGGAAGTG-GAGTTTGGCAGTG) of the etv6 gene. Parallel amplification of the β-actin gene was used as a control, as described.37 To quantify the relative expression of key hematopoietic genes, Q-RT-PCR was performed using iQ SYBR Green Supermix (Bio-Rad) and gene-specific primers detailed in Online Supplementary Table S1. All reactions were performed with 5 replicates using the Agilent Strategene MX3000P system, with data analyzed using the Livak method38 and expressed as a fold change normalized to the β-actin housekeeping gene, as described.25
WISH and DWISH
Whole-mount in situ hybridization (WISH) was performed on dechorionated embryos using digoxygenin (DIG)-labeled anti-sense probes, as described previously,34 with sense probes used in parallel as a negative control. For etv6, a probe encompassing the full-length transcript (1657 bp) was used.33 Double WISH was carried out essentially as described.39 Briefly, embryos were hybridized with an scl probe labeled with fluorescein-UTP and a etv6 probe labeled with DIG-UTP. The scl probe was detected first using an anti-fluoroscein alkaline phosphatase conjugate (Roche) and Fast Red (Roche) as a substrate. After removing the first antibody with acid treatment (0.1 M glycine-HCl pH 2.2, 0.1% Tween-20), the etv6 probe was then detected using an anti-DIG alkaline phosphatase conjugate (Roche) and NBT/BCIP (Roche) as a substrate.
Histochemical staining
To detect proliferation, embryos were incubated in 10 mM BrdU (Sigma) in Danieau water at 4°C for 20 min, rinsed and incubated at 28.5°C for 5 min, before staining for BrdU incorporation, as described.40 To detect apoptotic cells, embryos were incubated in 5 μg/mL acridine orange (Sigma) for 20 min, washed 8 times in egg-water and examined immediately under UV light or subjected to staining with anti-caspase 3 (BD Bioscience), as described.40
Results
Characterization of teleost etv6 genes
Consistent with other studies,4241 extensive bioinformatics analyses identified a single etv6 gene in both zebrafish and pufferfish, with the encoded protein showing high conservation to mammalian ETV6 proteins, particularly within the PNT and ETS domains where overall identity was more than 80% and more than 90%, respectively (Online Supplementary Figure S1A). Teleost etv6 genes showed conserved splicing (Online Supplementary Figure S1B) and synteny (Online Supplementary Figure S1C) with human ETV6, with the encoded etv6 proteins forming a clade with other vertebrate ETV6 proteins, which was distinct from the closely related ETV7 and SPDEF (SAM pointed domain containing ETS transcription factor) (Online Supplementary Figure S1D).
Embryonic expression profile of etv6 gene in zebrafish
To gain further insight into the role of ETV6 during embryogenesis, the spatio-temporal expression profile of zebrafish etv6 was investigated by whole-mount in situ hybridization using a full-length anti-sense probe. Transcripts of etv6 were evident in 1 cell embryos (Figure 1A), indicative of maternal derivation. By 12 hpf, this was replaced by zygotic expression restricted to bilateral stripes corresponding to the lateral plate mesoderm (LPM) (Figure 1B), which contains precursors for both blood and vasculature.22 By 18 hpf staining was seen in the LPM-derived anterior lateral mesoderm (ALM), pronephric duct and posterior intermediate cell mass (pICM) (Figure 1C and D), the sites of myeloid and erythromyeloid progenitor production, respectively, during the transient primitive wave of zebrafish hematopoiesis.43 The observed etv6 expression pattern was similar to that previously described for scl.44 Therefore, double in situ hybridization was performed with probes for both etv6 and scl. This indicated that etv6 was expressed in a subset of scl positive cells at this time point (Figure 1E1–E3). A similar pattern of expression was observed at 24 hpf (Figure 1F), but extending to the nascent pICM-derived posterior blood island (PBI). From 48 hpf, weak etv6 expression was detected in the vasculature, particularly the inter-segmental vessels between successive somites, the caudal hematopoietic tissue (CHT), a transient secondary site of hematopoiesis, as well as anteriorly (Figure 1G and H). By 72 hpf, etv6 expression was mostly anterior, including in the tectum, cerebellum, thymus, as well as in the developing gut and kidney, the latter being the ultimate site of definitive hematopoiesis (Figure 1I–J). This pattern was largely maintained up to 6 dpf, when additional expression was also observed within optic sensory epithelium (Figure 1K). No staining was observed using a sense probe as a control (Figure 1L–N). Blood and vasculature are derived from a common precursor, the hemangioblast,23 which can be specifically ablated with a morpholino targeting lycat.36 Injection of this morpholino resulted in a drastic reduction in the level of both scl (Figure 1O and P) and etv6 (Figure 1Q–T), the latter quantified by Q-RT-PCR at 3.6-fold (P<10). This collectively suggests that etv6 is expressed in hemangioblast-derived cells and likely participates in zebrafish embryonic development, including hematopoiesis.
Targeted knockdown of zebrafish etv6
To investigate the potential involvement of etv6 during zebrafish embryogenesis, an anti-sense morpholino mediated gene knockdown strategy was used. Two independent morpholinos were used to verify the specificity of the phenotypes observed: one targeting sequences upstream of the etv6 start codon (UTRmo) and the other targeting the donor splice-site for exon 2 (SSmo) (Figure 1U). RT-PCR using primers for exon 1 and 3 confirmed robust inhibition of splicing in the SSmo-injected embryos (Figure 1V), with Q-RT-PCR quantifying this as a highly significant 10.4-fold decrease (P<10). An alternatively-spliced product was also detected, the sequencing of which revealed it to represent a complex splice product with retained intronic sequence and use of an alternate exon, which would encode just the first 12 residues of etv6, followed by 35 novel residues before a stop codon (Figure 1W).
Zebrafish etv6 is involved in primitive hematopoiesis
Examination of embryos injected with either morpholino by light microscopy revealed no overt developmental disruption compared to control embryos, apart from a mild anemia. To further investigate the role of etv6 during hematopoiesis, specific blood lineage markers were investigated. At 14 hpf, etv6 and control morphant embryos showed equivalent expression of scl (Figure 2A and B), a marker of hemangioblasts,45 and gata1 (Figure 2C–F), an early erythroid marker.26 However, by 20 hpf the scl expression pattern was altered in etv6 morphant embryos, with increased expression rostrally and dorsally (Figure 2G–I, W), but reduced expression in the pICM (Figure 2K–M, X). Both of these phenotypes were able to be rescued by co-injection of morpholino-resistant etv6 mRNA (Figure 2J, N, W–X). A significant decrease in gata1 expression was also observed within the pICM at the same time point (Figure 2O–Q,Y), which could also be rescued (Figure 2R and Y). Finally, β-embryonic globin (β-e-g), a late erythroid marker,28 was similarly reduced in morphant embryos (Figure 2S–U, Z). Quantitative RT-PCR (Q-RT-PCR) expression analysis confirmed significantly reduced expression of both gata1 and β-e-g, but also revealed increased expression of erythropoietin (epo), indicating that defective epo signalling was not responsible (Figure 2V).
At 36 hpf, morphant signaling embryos showed significantly increased expression of gata1 (Figure 3A–C), but β-e-g expression (Figure 3D–F) and O-dianisidine staining of hemoglobin (Figure 3G–I) were both decreased. Analysis with Q-RT-PCR confirmed the increased gata1 and reduced β-e-g levels at this time point, with epo levels no longer statistically different to controls (Figure 3J). Differential blood cell counts at 48 hpf indicated a statistically-significant increase in pro-erythroblasts (Figure 3K), but no alterations in morphology were observed (Figure 3L).
The myeloid compartment was examined by analysis of spi1, an early pan-myeloid marker,25 lysozyme (lyz), a marker of early macrophages that develop rostrally and later heterophils,27 and mmp9, a marker of various cell populations including heterophils.30 At 14 hpf, spi1 expression was normal in etv6 morphants (Figure 4A–D). However, by 20 hpf there was a significant decrease in the number of cells expressing spi1 (Figure 4E–H) or lyz (Figure 4I–L) in the rostral part of the embryo. In contrast, a substantial increase in expression of mmp9 in the region around the cloaca was observed (Figure 4M–P). Histochemical analysis for myeloperoxidase (Figure 4Q–S), and Sudan Black (Figure 4T–V), which specifically stain heterophils,29 confirmed increased numbers of these cells at 31 hpf. Analysis of blood smears revealed an increased proportion of heterophils in morphants (Figure 3K), although a large proportion of these showed incomplete differentiation (Figure 4W–X).
Zebrafish etv6 affects definitive hematopoiesis
To explore the role of etv6 during definitive hematopoiesis, etv6 morphants were examined using a range of specific molecular markers. Knockdown of etv6 led to increased expression of runx146 at 36 hpf (Figure 5A–B, I′) that reached significance at 48 hpf (Figure 5C–D, I′) and c-myb31 from 36 hpf to 3 dpf (Figure 5E–H, I–K, I′), when c-myb positive precursors migrate from the CHT to the thymus. Q-RT-PCR analysis performed separately for the rostral and caudal regions of embryo showed that the increased expression was restricted to the caudal region (Figure 5J′). Conversely, by 5 dpf, c-myb was slightly reduced in the CHT, thymus and kidney of morphant embryos (Figure 5L–N, J′), indicative of a disruption of progenitor cells. Morphant embryos were also overtly anemic by light microscopy, which was confirmed by reduced O-dianisidine staining at 4 dpf (Figure 5O–Q) and β-e-g expression at 5 dpf (Figure 5U–W, J′). Interestingly, this was despite increased gata1 at 5 dpf (Figure 5R–T), confirmed by Q-RT-PCR at 5 dpf when epo expression was also increased and epor expression was normal (Figure 5J′), confirming the reduced erythroid differentiation was not due to defective epo signaling. Morphant embryos maintained significantly increased numbers of circulating pro-erythroblasts (Figure 5K′–L′), although these are largely derived from primitive erythropoiesis at this time point.47 Analysis of BrdU incorporation revealed increased proliferation within the CHT at 3 dpf (Figure 5X–B′), whereas staining with acridine orange (Figure 5C′ and D′) and anti-caspase 3 (Figure 5E′–H′) indicated enhanced apoptosis in this region at 4–5 dpf.
To examine the role of etv6 in definitive myeloid cell development, the myeloid specific markers, lyz and mmp9, were also examined at 5 dpf. Interestingly, morphant embryos showed a modest expansion of lyz+ cells (Figure 6A–C, E), which could be rescued by co-injection of morpholino-resistant etv6 mRNA (Figure 6D and E). In contrast, there was a reduction of mmp9+ cells (Figure 6F–I), with this differential effect confirmed by Q-RT-PCR analysis of the respective genes (Figure 6W). Blood examination at 5 dpf revealed elevated numbers of monocyte/macrophages in morphant embryos compared to controls, while in contrast circulating heterophils were lessened in morphants, although this did not reach significance (Figure 5K′ and L′). Finally, lymphopoiesis was investigated through evaluation of the lymphoid markers ikaros24 and rag1.32 In etv6 morphant embryos expression of ikaros was increased at 3 dpf (Figure 6J–M) and 5 dpf (Figure 6N–Q). Expression of the late lymphoid marker rag1 was also increased at 5 dpf (Figure 6R–T, V), with this phenotype able to be rescued by morpholino-resistant etv6 mRNA (Figure 6U and V). The increased expression of lymphoid genes in morphants was confirmed by Q-RT-PCR analysis (Figure 6X). In addition, morphant embryos showed higher lymphocyte numbers in peripheral blood smears at 5 dpf (Figure 5K′ and L′). Moreover, no difference was observed in expression of the thymic epithelium marker foxn1 (Figure 6Y and Z). This collectively indicates enhanced lymphopoiesis in etv6 morphants.
Discussion
Despite the frequent involvement of the ETV6 gene in hematologic malignancies, much remains to be learned about the role of ETV6 during normal hematopoietic development. This is partly related to the embryonic lethality of Etv6-knockout mice due to a failure in angiogenesis,202 which has complicated more detailed studies. Since embryonic development in zebrafish is not dependent on vasculogenesis, we hypothesized that this organism would be a useful alternative vertebrate model for investigating the function of ETV6 during embryogenesis. This study has characterized the zebrafish etv6 gene, and delineated its role during embryonic hematopoiesis, where it acts at multiple levels to influence the production of blood and immune cells.
In agreement with other work,4241 bioinformatic analysis revealed that the zebrafish possessed a single etv6 protein with high sequence homology with other vertebrate ETV6 proteins, especially within the PNT and ETS domains, indicating functional conservation. Expression studies showed zebrafish etv6 transcripts were found to be initially maternally-derived, with specific zygotic expression evident from 12 hpf in the LPM in a subset of scl positive hemangioblasts.22 By 18 hpf, expression was seen in the anterior lateral mesoderm (ALM) and posterior intermediate cell mass (pICM), the sites of primitive myelopoiesis and erythropoiesis,43 and by 24 hpf staining was also observed in the nascent posterior blood island (PBI), and later in vessels. At 3 dpf, etv6 expression was evident in the thymus, the site of lymphopoiesis, and later in the developing kidney, the site of definitive hematopoiesis. Expression was drastically reduced in embryos in which hemangioblasts were ablated. This is consistent with the expression studies in Xenopus,19 mice18 and in various hematopoietic cell lines,18 suggesting a conserved role in blood and immune cell development across vertebrates. Expression also overlapped with that for the related etv7 gene.48
The earliest zebrafish hematopoietic cells are derived from hemangioblasts in the LPM at 12 hpf,22 characterized by the expression of markers for hematopoietic progenitors, such as scl, as well as those for early myeloid (spi1) and erythroid (gata1) populations.262523 Morpholino-mediated knockdown of etv6 did not alter the expression of early hematopoietic markers, suggesting that hematopoietic cell specification was etv6-independent. However, at 20 hpf there was differential effect on scl populations, with an increase within ventral, non-hematopoietic tissue, but a reduction of caudal expression in hematopoietic tissue, suggesting that etv6 may influence the early hematopoietic progenitor compartment. This would potentially explain the reduced levels of early (spi1) and late (lyz) myeloid cells rostrally, and reduced early (gata1) and late (β-e-g) erythroid cells caudally. Interestingly, there was a specific increase in the mmp9+ cells caudally, suggesting that etv6 might also influence lineage choice during primitive hematopoiesis in this region. This is the first study demonstrating the involvement of ETV6 during primitive hematopoiesis, and is in contrast with previous studies that have reported unaffected yolk sac and fetal liver hematopoiesis in Etv6−/− mice,202 which may represent a genuine difference between the two species.
Definitive HSCs in zebrafish originate in the dorsal aorta and migrate first to the CHT before seeding the kidney and thymus.47 Morphant embryos showed a significant increase in cells expressing runx1 and c-myb within the dorsal aorta and CHT, which correlated with increased proliferation in the latter. However, by 5 dpf, etv6 morphants showed an overall decrease in c-myb expression, along with increased apoptosis in this region, suggesting etv6 may impact on cell survival. This is consistent with the failure of Etv6−/− progenitors to contribute to bone marrow hematopoiesis in chimeric mouse,18 and the loss of bone marrow HSCs in mice with Etv6 specifically inactivated in the hematopoietic compartment.20 Interestingly, etv6 morphant Xenopus embryos exhibited a more severe phenotype, with HSCs completely ablated, although this was secondary to a severe defect in artery formation.19 An increase in lymphopoiesis was also observed in zebrafish etv6 morphants concomitant with the loss of c-myb+ cells, suggesting that etv6-deficiency may result in preferential differentiation down this lineage. This observation may be of clinical relevance, providing one possible explanation for the high propensity of ETV6 fusions in lymphoid malignancies.
The role of ETV6 in erythropoiesis has remained controversial. Previous work has shown that selective excision of Etv6 in the erythroid lineage of mice failed to impact on erythropoiesis.20 However, other data have demonstrated that overexpression of ETV6 enhanced erythroid differentiation in cell models,49 as well as leading to increased erythroid precursors, accelerated differentiation and augmented globin expression in mice transgenic for ETV6.21 Our data are consistent with the latter studies, with etv6 morphants showing an initial decrease in gata1 expression, followed by a sustained increase in expression. However, despite this increase in early erythroid cells (and a parallel induction of epo) etv6 morphants remained anemic, with decreased β-e-g expression and increased erythroblasts in the blood. This collectively suggests a role for etv6 in the regulation of red blood cell maturation. Expression of etv7, which also contributes to red blood cell maturation,48 was reduced in etv6 morphants. This suggests the two genes may act co-ordinately in this process.
Our data also revealed that etv6 influences the differentiation of zebrafish heterophils, the piscine neutrophil equivalent. Morphant embryos showed incomplete heterophil differentiation at 48 hpf and reduced numbers of mmp9+ heterophils at 5 dpf. Close examination of the published study using chimeric mice revealed that while Etv6−/− cells were able to contribute to all definitive hematopoietic lineages, the granulocyte/macrophage lineage was under-represented,18 and the study on the hematopoietic-specific disruption of Etv6 described reduced neutrophils, despite normal red cell and lymphocyte numbers.20 A role for ETV6 in regulating myeloid differentiation might also be relevant in the context of ETV6 fusions in myeloid malignancies.
Finally, ETV6 has been implicated in angiogenesis, with yolk sac angiogenesis disrupted in Etv6−/− mice,2 and arterial differentiation ablated in etv6 morphant Xenopus embryos due to loss of VEGFA expression.19 A more subtle defect was recently reported following etv6 knockdown in zebrafish embryos, with aberrant trajectories and stalled sprouts observed during intersegmental vessel (ISV) formation.50 To verify this, etv6 SSmo was injected into flk1:gfp transgenic embryos, which resulted in similar subtle ISV defects (Online Supplementary Figure S2A–C), confirming this distinct angiogenic role, which may be an indirect consequence of the altered scl expression seen in etv6 morphants. No other vascular defects were observed (data not shown). Moreover, overexpression of etv6 had no significant effect on circulation (Online Supplementary Figure S2D). Collectively, our data suggest that ETV6 participates in both blood and, to a lesser extent, vessel development, consistent with their common derivation from the hemangioblast, and the expression of ETV6 in both lineages.
Acknowledgments
The authors would like to thank the Deakin University Upper Animal House staff for their assistance with zebrafish husbandry, as well as Dr. Daniel McCulloch and Dr. Yann Gibert for helpful discussions.
Footnotes
- The online version of this article has a Supplementary Appendix.
- Authorship and Disclosures Information on authorship, contributions, and financial & other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org
- Funding The authors acknowledge support from the Deakin University International Research Scholarship scheme (PR, SMNO) and Alfred Deakin Postdoctoral Research Fellow scheme (CL), and access to the resources of FishWorks: Collaborative Infrastructure for Zebrafish Research, an Australian Research Council LIEF initiative (ACW).
- Received January 29, 2014.
- Accepted September 29, 2014.
References
- Oikawa T, Yamada T. Molecular biology of the Ets family of transcription factors. Gene. 2003; 303(1):11-34. PubMedhttps://doi.org/10.1016/S0378-1119(02)01156-3Google Scholar
- Wang LC, Kuo A, Fujiwara Y, Gilliland DG, Golub TR, Orkin SH. Yolk sac angiogenic defects and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL. EMBO J. 1997; 16(14):4374-83. PubMedhttps://doi.org/10.1093/emboj/16.14.4374Google Scholar
- Golub TR, McLean T, Stegmaier K, Carroll M, Tomasson M, Gilliland DG. The TEL gene and human leukemia. Biochim Biophys Acta. 1996; 1288(1):M7-10. PubMedGoogle Scholar
- Chakrabarti SR, Nucifora G. The leukemia-associated gene TEL encodes a transcription repressor which associates with SMRT and mSin3A. Biochem Biophys Res Commun. 1999; 264(3):871-7. PubMedhttps://doi.org/10.1006/bbrc.1999.1605Google Scholar
- Kim CA, Phillips ML, Kim W, Gingery M, Tran HH, Robinson MA. Polymerization of the SAM domain of TEL in leukemogenesis and transcriptional repression. EMBO J. 2001; 20(15):4173-82. PubMedhttps://doi.org/10.1093/emboj/20.15.4173Google Scholar
- Potter MD, Buijs A, Kreider B, van Rompaey L, Grosveld GC. Identification and charac-terization of a new human ETS-family transcription factor, TEL2, that is expressed in hematopoietic tissue and can associate with TEL1/ETV6. Blood. 2000; 95(11):3341-8. PubMedGoogle Scholar
- Wood LD, Irvin BJ, Nucifora G, Luce KS, Hiebert SW. Small ubiquitin-like modifier conjugation regulates nuclear export of TEL, a putative tumor suppressor. Proc Natl Acad Sci USA. 2003; 100(6):3257-62. PubMedhttps://doi.org/10.1073/pnas.0637114100Google Scholar
- Poirel H, Oury C, Carron C, Duprez E, Laabi Y, Tsapis A. The TEL gene products: nuclear phosphoproteins with DNA binding properties. Oncogene. 1997; 14(3):349-57. PubMedhttps://doi.org/10.1038/sj.onc.1200829Google Scholar
- Guidez F, Petrie K, Ford AM, Lu H, Bennett CM, MacGregor A. Recruitment of the nuclear receptor corepressor N-CoR by TEL moiety of the childhood leukemia-associated TEL-AML1 oncoprotein. Blood. 2000; 96(7):2557-60. PubMedGoogle Scholar
- Wang L, Hiebert SW. TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3. Oncogene. 2001; 20(28):3716-25. PubMedhttps://doi.org/10.1038/sj.onc.1204479Google Scholar
- De Braekeleer E, Douet-Guilbert N, Morel F, Le Bris M-J, Basinko A, De Braekeleer M. ETV6 fusion genes in hematological malignancies: A review. Leuk Res. 2012; 36(8):945-61. PubMedhttps://doi.org/10.1016/j.leukres.2012.04.010Google Scholar
- Peeters P, Raynaud SD, Cools J, Wlodarska I, Grosgeorge J, Philip P. Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia. Blood. 1997; 90(7):2535-40. PubMedGoogle Scholar
- Golub TR, Barker GF, Bohlander SK, Hiebert SW, Ward DC, Bray-Ward P. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci USA. 1995; 92(11):4917-21. PubMedhttps://doi.org/10.1073/pnas.92.11.4917Google Scholar
- Buijs A, Sherr S, van Baal S, van Bezouw S, van der Plas D, van Kessel GA. Translocation (12; 22)(p13; q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11. Oncogene. 1995; 10(8):1511-9. PubMedGoogle Scholar
- Patel N, Goff LK, Clark T, Ford AM, Foot N, Lillington D. Expression profile of wild-type ETV6 in childhood acute leukaemia. Br J Haematol. 2003; 122(1):94-8. PubMedhttps://doi.org/10.1046/j.1365-2141.2003.04399.xGoogle Scholar
- Raynaud S, Cave H, Baens M, Bastard C, Cacheux V, Grosgeorge J. The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood. 1996; 87(7):2891-9. PubMedGoogle Scholar
- Barjesteh van Waalwijk van Doorn-Khosravani S, Spensberger D, de Knegt Y, Tang M, Lowenberg B, Delwel R. Somatic heterozygous mutations in ETV6 (TEL) and frequent absence of ETV6 protein in acute myeloid leukemia. Oncogene. 2005; 24(25):4129-37. PubMedhttps://doi.org/10.1038/sj.onc.1208588Google Scholar
- Wang LC, Swat W, Fujiwara Y, Davidson L, Visvader J, Kuo F. The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow. Genes Dev. 1998; 12(15):2392-402. PubMedhttps://doi.org/10.1101/gad.12.15.2392Google Scholar
- Ciau-Uitz A, Pinheiro P, Gupta R, Enver T, Patient R. Tel1/ETV6 specifies blood stem cells through the agency of VEGF signaling. Dev Cell. 2010; 18(4):569-78. PubMedhttps://doi.org/10.1016/j.devcel.2010.02.009Google Scholar
- Hock H, Meade E, Medeiros S, Schindler JW, Valk PJ, Fujiwara Y. Tel/Etv6 is an essential and selective regulator of adult hematopoietic stem cell survival. Genes Dev. 2004; 18(19):2336-41. PubMedhttps://doi.org/10.1101/gad.1239604Google Scholar
- Eguchi-Ishimae M, Eguchi M, Maki K, Porcher C, Shimizu R, Yamamoto M. Leukemia-related transcription factor TEL/ETV6 expands erythroid precursors and stimulates hemoglobin synthesis. Cancer Sci. 2009; 100(4):689-97. PubMedhttps://doi.org/10.1111/j.1349-7006.2009.01097.xGoogle Scholar
- Davidson AJ, Zon LI. The ‘definitive’ (and ‘primitive’) guide to zebrafish hematopoiesis. Oncogene. 2004; 23(43):7233-46. PubMedhttps://doi.org/10.1038/sj.onc.1207943Google Scholar
- Patterson LJ, Gering M, Eckfeldt CE, Green AR, Verfaillie CM, Ekker SC. The transcription factors Scl and Lmo2 act together during development of the hemangioblast in zebrafish. Blood. 2007; 109(6):2389-98. PubMedhttps://doi.org/10.1182/blood-2006-02-003087Google Scholar
- Willett CE, Kawasaki H, Amemiya CT, Lin S, Steiner LA. Ikaros expression as a marker for lymphoid progenitors during zebrafish development. Dev Dyn. 2001; 222(4):694-8. PubMedhttps://doi.org/10.1002/dvdy.1223Google Scholar
- Lieschke GJ, Oates AC, Paw BH, Thompson MA, Hall NE, Ward AC. Zebrafish SPI-1(PU.1) marks a site of myeloid development independent of primitive erythropoiesis: implications for axial patterning. Dev Biol. 2002; 246(2):274-95. PubMedhttps://doi.org/10.1006/dbio.2002.0657Google Scholar
- Long Q, Meng A, Wang H, Jessen JR, Farrell MJ, Lin S. GATA-1 expression pattern can be recapitulated in living transgenic zebrafish using GFP reporter gene. Development. 1997; 124(20):4105-11. PubMedGoogle Scholar
- Liu F, Wen Z. Cloning and expression pattern of the lysozyme C gene in zebrafish. Mech Dev. 2002; 113(1):69-72. PubMedhttps://doi.org/10.1016/S0925-4773(01)00658-XGoogle Scholar
- Brownlie A, Hersey C, Oates AC, Paw BH, Falick AM, Witkowska HE. Characterization of embryonic globin genes of the zebrafish. Dev Biol. 2003; 255(1):48-61. PubMedhttps://doi.org/10.1016/S0012-1606(02)00041-6Google Scholar
- Lieschke GJ, Oates AC, Crowhurst MO, Ward AC, Layton JE. Morphologic and functional characterization of granulocytes and macrophages in embryonic and adult zebrafish. Blood. 2001; 98(10):3087-96. PubMedhttps://doi.org/10.1182/blood.V98.10.3087Google Scholar
- Yoong S, O’Connell B, Soanes A, Crowhurst MO, Lieschke GJ, Ward AC. Characterization of the zebrafish matrix metalloproteinase 9 gene and its developmental expression pattern. Gene Expr Patterns. 2007; 7(1–2):39-46. PubMedhttps://doi.org/10.1016/j.modgep.2006.05.005Google Scholar
- Murayama E, Kissa K, Zapata A, Mordelet E, Briolat V, Lin H-F. Tracing hematopoietic precursor migration to successive hematopoietic organs during zebrafish development. Immunity. 2006; 25(6):963-75. PubMedhttps://doi.org/10.1016/j.immuni.2006.10.015Google Scholar
- Willett CE, Cherry JJ, Steiner L. Characterization and expression of the recombination activating genes (rag1 and rag2) of zebrafish. Immunogenetics. 1997; 45(6):394-404. PubMedhttps://doi.org/10.1007/s002510050221Google Scholar
- Onnebo SMN, Condron MM, McPhee DO, Lieschke GJ, Ward AC. Hematopoietic perturbation in zebrafish expressing a tel-jak2a fusion. Exp Hematol. 2005; 33(2):182-8. PubMedhttps://doi.org/10.1016/j.exphem.2004.10.019Google Scholar
- Onnebo SM, Rasighaemi P, Kumar J, Liongue C, Ward AC. Alternate TEL-JAK2 fusions associated with T cell acute lymphoblastic leukemia and atypical chronic myelogenous leukemia dissected in zebrafish. Haematologica. 2012; 97(12):1895-903. PubMedhttps://doi.org/10.3324/haematol.2012.064659Google Scholar
- Sabaawy HE, Azuma M, Embree LJ, Tsai HJ, Starost MF, Hickstein DD. TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia. Proc Natl Acad Sci USA. 2006; 103(41):15166-71. PubMedhttps://doi.org/10.1073/pnas.0603349103Google Scholar
- Xiong JW, Yu Q, Zhang J, Mably JD. An acyltransferase controls the generation of hematopoietic and endothelial lineages in zebrafish. Circ Res. 2008; 102(9):1057-64. PubMedhttps://doi.org/10.1161/CIRCRESAHA.107.163907Google Scholar
- O'Sullivan LA, Noor SM, Trengove MC, Lewis RS, Liongue C, Sprigg NS. Suppressor of cytokine signaling 1 regulates embryonic myelopoiesis independently of its effects on T cell development. J Immunol. 2011; 186(8):4751-61. PubMedhttps://doi.org/10.4049/jimmunol.1000343Google Scholar
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001; 25(4):402-8. PubMedhttps://doi.org/10.1006/meth.2001.1262Google Scholar
- Jowett T. Double in situ hybridization techniques in zebrafish. Methods. 2001; 23(4):345-58. PubMedhttps://doi.org/10.1006/meth.2000.1147Google Scholar
- Verduzco D, Amatruda JF. Analysis of cell proliferation, senescence and cell death in zebrafish embryos. Meth Cell Biol. 2011;1011-19. Google Scholar
- Montpetit A, Sinnett D. Comparative analysis of the ETV6 gene in vertegrate genomes from pufferfish to human. Oncogene. 2001; 20(26):3437-42. PubMedhttps://doi.org/10.1038/sj.onc.1204444Google Scholar
- Liu F, Patient R. Genome-wide analysis of the zebrafish ETS family identifies three genes required for hemangioblast differentiation or angiogenesis. Circ Res. 2008; 103(10):1147-54. PubMedhttps://doi.org/10.1161/CIRCRESAHA.108.179713Google Scholar
- Bertrand JY, Kim AD, Violette EP, Stachura DL, Cisson JL, Traver D. Definitive hematopoiesis initiates through a committed erythromyeloid progenitor in the zebrafish embryo. Development. 2007; 134(23):4147-56. PubMedhttps://doi.org/10.1242/dev.012385Google Scholar
- Gering M, Rodaway ARF, Gottens B, Patient R, Green AR. The SCL gene specifies haemangioblast development from early mesoderm. EMBO J. 1998; 17(14):4029-45. PubMedhttps://doi.org/10.1093/emboj/17.14.4029Google Scholar
- Liao EC, Paw BH, Oates AC, Pratt SJ, Postlethwait JH, Zon LI. SCL/Tal-1 transcription factor acts downstream of cloche to specify hematopoietic and vascular progenitors in zebrafish. Genes Dev. 1998; 12(5):621-6. PubMedhttps://doi.org/10.1101/gad.12.5.621Google Scholar
- Lam EY, Hall CJ, Crosier PS, Crosier KE, Flores MV. Live imaging of Runx1 expression in the dorsal aorta tracks the emergence of blood progenitors from endothelial cells. Blood. 2010; 116(6):909-14. PubMedhttps://doi.org/10.1182/blood-2010-01-264382Google Scholar
- Paik EJ, Zon LI. Hematopoietic development in the zebrafish. Int J Dev Biol. 2010; 54(6–7):1127-37. PubMedhttps://doi.org/10.1387/ijdb.093042epGoogle Scholar
- Quintana AM, Picchione F, Klein Geltink RI, Taylor MR, Grosveld GC. Zebrafish ETV7 regulates red blood cell development through the cholesterol synthesis pathway. Disease models & mechanisms. 2014; 7(2):265-70. PubMedhttps://doi.org/10.1242/dmm.012526Google Scholar
- Takahashi W, Sasaki K, Kvomatsu N, Mitani K. TEL/ETV6 accelerates erythroid differentiation and inhibits megakaryocytic maturation in a human leukemia cell line UT-7/GM. Cancer Sci. 2005; 96(6):340-8. PubMedhttps://doi.org/10.1111/j.1349-7006.2005.00052.xGoogle Scholar
- Roukens MG, Alloul-Ramdhani M, Baan B, Kobayashi K, Peterson-Maduro J, van Dam H. Control of endothelial sprouting by a Tel-CtBP complex. Nature Cell Biol. 2010; 12(10):933-42. PubMedhttps://doi.org/10.1038/ncb2096Google Scholar